News
Feed
Events
Feed
News
+ Events
Feed

Andera Partners

Aktuelle News

26 Juli 2024

09:00 Corporate EN

Andera Partners

Corporate
EN

Andera Partners Co-Leads $196 Million Round for Kestra Medical and Welcomes Raymond W. Cohen to Board of Directors

25 Juli 2024

10:00 Corporate

Andera Partners

Corporate

Andera Partners’ Portfoliounternehmen JenaValve von Edwards Lifesciences übernommen

09:30 Corporate

Andera Partners

Corporate

Andera Partners Portfoliounternehmen TRiCares sammelt 50 Mio. USD in Serie D-Finanzierung ein

15 Juli 2024

09:30 Corporate EN

Andera Partners

Corporate
EN

Andera Partners’ portfolio company Amolyt Pharma completes acquisition by AstraZeneca

9 Juli 2024

08:10 Corporate

Andera Partners

Corporate

Andera Partners führt gemeinsam mit einem Konsortium eine 63 Mio. € Serie A-Finanzierung für das Münchner Autoimmun-Biotechunternehmen SciRhom an

14 März 2024

11:10 Corporate

Andera Partners

Corporate

Andera Partners‘ Portfoliounternehmen Tubulis schließt überzeichnete Serie B2-Finanzierungsrunde in Höhe von 128 Mio. € ab, um die Entwicklung seiner ADC-Pipeline zu beschleunigen

09:00 Corporate EN

Andera Partners

Corporate
EN

Amolyt Pharma, an Andera Partners’ portfolio company, announces its sale to AstraZeneca

14 November 2023

07:15 Corporate

Andera Partners

Corporate

Andera Partners führt überzeichnete 67,5 Mio. € Serie-C-Finanzierung für das Krebsimmuntherapie-Unternehmen Nouscom an

15 Mai 2023

09:00 Corporate EN

Andera Partners

Corporate
EN

Andera Partners co-leads a €40 million Series A of Dualyx, a Belgian biotech developing novel Treg therapies for autoimmune diseases

10 Mai 2023

09:00 Corporate

Andera Partners

Corporate

Andera Partners ernennt Stefan Keitel zum Senior Advisor für die DACH-Region und stärkt damit seine Präsenz auf dem deutschen, österreichischen und schweizerischen Private Equity-Markt

18 April 2023

09:15 Corporate EN

Andera Partners

Corporate
EN

Andera Partners co-leads a Series A extension round totalling € 47.75 million for radiopharmaceutical company Ariceum Therapeutics

13 April 2023

12:45 Corporate EN

Andera Partners

Corporate
EN

Andera Partners leads $48.5 Million Series A financing for medical device company BioVentrix®

15 März 2023

13:05 Corporate EN

Andera Partners

Corporate
EN

Andera Partners co-leads $25m extension round for FIRE1, an Irish medtech developing breakthrough technology for patients with heart failure

16 Februar 2023

09:00 Corporate EN

Andera Partners

Corporate
EN

Ahead of its business plan, Andera Partners approaches 4 billion euros in assets under management and announces a new 2028 target of 6 to 8 billion euros

14 Februar 2023

09:00 Corporate EN

Andera Partners

Corporate
EN

Andera Partners Portfolio Company Mineralys Therapeutics Successfully Completes Upsized $192 Million Nasdaq IPO

26 Januar 2023

13:10 Corporate EN

Andera Partners

Corporate
EN

Andera Partners Participates in the €45 Million Series B Financing of Grey Wolf Therapeutics, led by Pfizer Ventures, to Advance First-of-its-Kind Neoantigen Creation Approaches

10 Januar 2023

08:30 Corporate EN

Andera Partners

Corporate
EN

Andera Partners invests in SoniVie, a medtech company developing a promising device for the treatment of hypertension

9 Januar 2023

14:00 Corporate EN

Andera Partners

Corporate
EN

Andera Partners participates in the $138 Million Series C Financing of Amolyt Pharma led by Sofinnova Partners and co-led by Intermediate Capital Group

10 Oktober 2022

10:00 Corporate

Andera Partners

Corporate

Andera Partners erhält 456 Millionen Euro für seinen bisher größten Life Sciences Fonds und bestätigt so die Attraktivität des Sektors und seines Impacts

7 Juli 2022

10:15 Corporate EN

Andera Partners

Corporate
EN

Andera Partners strengthens its Life Sciences team with a new partner

8 Juni 2022

14:05 Corporate EN

Andera Partners

Corporate
EN

Andera Partners co-leads $118 Million Oversubscribed Series B Financing of Mineralys Therapeutics to Advance the Development of Novel, Targeted Treatment for Hypertension

3 Mai 2022

11:05 Corporate EN

Andera Partners

Corporate
EN

Andera Partners supports Tubulis in a €60 million Series B financing to accelerate the development of its ADCs

7 April 2022

12:59 Corporate

Andera Partners

Corporate

Andera Partners veräußert Beteiligung an Life Science-Portfoliounternehmen ReViral an Pfizer

22 Februar 2022

09:30 Corporate EN

Andera Partners

Corporate
EN

Andera Partners supports TargED Biopharmaceuticals in €39 million Series A financing to bring groundbreaking thrombolytic treatment to patients

2 August 2021

14:05 Corporate EN

Andera Partners

Corporate
EN

Andera Partners’ Portfolio Company T-knife Announces $110 Million Series B Financing to Advance Pipeline of T-cell Receptor Therapies

27 April 2021

10:00 Corporate

Andera Partners

Corporate

Andera Partners stärkt seine Präsenz in der DACH-Region

Anstehende Events

Keine Events gefunden